Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dana M Jensen

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|September 28, 2018
Minimal mosaicism, maximal phenotype: Discordance between clinical and molecular findings in two patients with tuberous sclerosisHeather M Byers, Dana M Jensen, Ian A Glass, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 5, 2020
Cell-free DNA as a diagnostic analyte for molecular diagnosis of vascular malformationsKaitlyn Zenner, Dana M Jensen, Tori T Cook, et al.
JCI Insight|September 20, 2019
Genotype correlates with clinical severity in PIK3CA-associated lymphatic malformationsKaitlyn Zenner, Chi Vicky Cheng, Dana M Jensen, et al.
American Journal of Medical Genetics. Part A|August 1, 2018
Characterization of a severe case of PIK3CA-related overgrowth at autopsy by droplet digital polymerase chain reaction and report of PIK3CA sequencing in 22 patientsAndrew M Piacitelli, Dana M Jensen, Heather Brandling-Bennett, et al.
International Journal of Pediatric Otorhinolaryngology|September 19, 2021
Acetylsalicylic acid suppression of the PI3K pathway as a novel medical therapy for head and neck lymphatic malformationsJuliana Bonilla-Velez, Kathryn B Whitlock, Sheila Ganti, et al.
International Journal of Pediatric Otorhinolaryngology|December 2, 2022
Primary targeted medical therapy for management of bilateral head and neck lymphatic malformations in infantsClare M Richardson, Jonathan N Perkins, Kaitlyn Zenner, et al.
HGG Advances|April 4, 2022
Somatic activating <i>BRAF</i> variants cause isolated lymphatic malformationsKaitlyn Zenner, Dana M Jensen, Victoria Dmyterko, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 6, 2022
Alpelisib for the treatment of PIK3CA-related head and neck lymphatic malformations and overgrowthTara L Wenger, Sheila Ganti, Catherine Bull, et al.
The Journal of Investigative Dermatology|April 23, 2023
Upregulated MicroRNA-21 Drives the Proliferation of Lymphatic Malformation Endothelial Cells by Inhibiting PDCD4Ravi W Sun, Haihong Zhang, Syed J Mehdi, et al.
American Journal of Human Genetics|April 16, 2019
Homozygous Mutations in CSF1R Cause a Pediatric-Onset Leukoencephalopathy and Can Result in Congenital Absence of MicrogliaNynke Oosterhof, Irene J Chang, Ehsan Ghayoor Karimiani, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|September 28, 2018
Minimal mosaicism, maximal phenotype: Discordance between clinical and molecular findings in two patients with tuberous sclerosisHeather M Byers, Dana M Jensen, Ian A Glass, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 5, 2020
Cell-free DNA as a diagnostic analyte for molecular diagnosis of vascular malformationsKaitlyn Zenner, Dana M Jensen, Tori T Cook, et al.
JCI Insight|September 20, 2019
Genotype correlates with clinical severity in PIK3CA-associated lymphatic malformationsKaitlyn Zenner, Chi Vicky Cheng, Dana M Jensen, et al.
American Journal of Medical Genetics. Part A|August 1, 2018
Characterization of a severe case of PIK3CA-related overgrowth at autopsy by droplet digital polymerase chain reaction and report of PIK3CA sequencing in 22 patientsAndrew M Piacitelli, Dana M Jensen, Heather Brandling-Bennett, et al.
International Journal of Pediatric Otorhinolaryngology|September 19, 2021
Acetylsalicylic acid suppression of the PI3K pathway as a novel medical therapy for head and neck lymphatic malformationsJuliana Bonilla-Velez, Kathryn B Whitlock, Sheila Ganti, et al.
International Journal of Pediatric Otorhinolaryngology|December 2, 2022
Primary targeted medical therapy for management of bilateral head and neck lymphatic malformations in infantsClare M Richardson, Jonathan N Perkins, Kaitlyn Zenner, et al.
HGG Advances|April 4, 2022
Somatic activating <i>BRAF</i> variants cause isolated lymphatic malformationsKaitlyn Zenner, Dana M Jensen, Victoria Dmyterko, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 6, 2022
Alpelisib for the treatment of PIK3CA-related head and neck lymphatic malformations and overgrowthTara L Wenger, Sheila Ganti, Catherine Bull, et al.
The Journal of Investigative Dermatology|April 23, 2023
Upregulated MicroRNA-21 Drives the Proliferation of Lymphatic Malformation Endothelial Cells by Inhibiting PDCD4Ravi W Sun, Haihong Zhang, Syed J Mehdi, et al.
American Journal of Human Genetics|April 16, 2019
Homozygous Mutations in CSF1R Cause a Pediatric-Onset Leukoencephalopathy and Can Result in Congenital Absence of MicrogliaNynke Oosterhof, Irene J Chang, Ehsan Ghayoor Karimiani, et al.
Pageof 2